Curis Lifesciences Shareholding Pattern & Promoter Holding
Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026
As of Sep 2026, promoters hold 68.03% of Curis Lifesciences, FIIs hold 1.05%, DIIs hold 4.63% and the public holds 26.29%. Promoter holding was unchanged from Mar 2026.
Get an alert when Curis Lifesciences reports results or its shareholding changes. Free account.
Promoters
68.03%
unchanged QoQ
FIIs
1.05%
−0.14 pp QoQ
DIIs
4.63%
−1.17 pp QoQ
Public
26.29%
+1.31 pp QoQ
Curis Lifesciences shareholding, quarter by quarter
| Quarter | Promoters | FIIs | DIIs | Public | Shareholders |
|---|---|---|---|---|---|
| Sep 2026 | 68.03% | 1.05% | 4.63% | 26.29% | 315 |
| Mar 2026 | 68.03% | 1.19% | 5.80% | 24.98% | 340 |
| Nov 2025 | 68.03% | 2.93% | 10.86% | 18.17% | 542 |
Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.
Value of the promoter stake
At a market capitalisation of ₹138 cr, the promoter group's 68.03% stake is worth ₹94 cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.
Promoter holding in Pharmaceuticals & Biotechnology peers
Curis Lifesciences shareholding: common questions
What is the promoter holding in Curis Lifesciences?
Promoters hold 68.03% of Curis Lifesciences as of Sep 2026. Their stake was unchanged from Mar 2026.
How much do FIIs hold in Curis Lifesciences?
Foreign institutional investors (FIIs) held 1.05% of Curis Lifesciences in Sep 2026, −0.14 pp versus Mar 2026.
How much do mutual funds and other DIIs hold in Curis Lifesciences?
Domestic institutional investors (DIIs), which include mutual funds and insurers, held 4.63% of Curis Lifesciences in Sep 2026, −1.17 pp versus Mar 2026.
Is the promoter holding in Curis Lifesciences pledged?
The latest disclosed shareholding pattern shows no pledged promoter shares in Curis Lifesciences.
How many shareholders does Curis Lifesciences have?
Curis Lifesciences had 315 shareholders in Sep 2026, compared with 340 in Mar 2026.